MONTVALE, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its fourth quarter and full year 2006 financial results on Thursday, February 22, 2007, before the U.S. financial markets open. Management will provide a Company update and discuss the fourth quarter and full year 2006 results during a conference call on Thursday, February 22, 2007, at 9:00 a.m. EST.
Investors and other interested parties may access the call as follows: Date: Thursday, February 22, 2007 Time: 9:00 a.m. EST Telephone (U.S.): 866.356.4281 Telephone (international): 617.597.5395 Participant Passcode: 11640389 Webcast: http://www.memorypharma.com under the "Investors" section
An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, February 22, 2007, until Thursday, March 1, 2007. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 50028326. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, General Council, +1-201-802-7249; or LilianStern, Stern Investor Relations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
